148 related articles for article (PubMed ID: 9066724)
1. Opioid growth factor (OGF) inhibits human pancreatic cancer transplanted into nude mice.
Zagon IS; Hytrek SD; Smith JP; McLaughlin PJ
Cancer Lett; 1997 Jan; 112(2):167-75. PubMed ID: 9066724
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of opioid growth factor receptor in human pancreatic adenocarcinoma.
Zagon IS; Smith JP; Conter R; McLaughlin PJ
Int J Mol Med; 2000 Jan; 5(1):77-84. PubMed ID: 10601579
[TBL] [Abstract][Full Text] [Related]
3. Opioid growth factor ([Met5]enkephalin) prevents the incidence and retards the growth of human colon cancer.
Zagon IS; Hytrek SD; Lang CM; Smith JP; McGarrity TJ; Wu Y; McLaughlin PJ
Am J Physiol; 1996 Sep; 271(3 Pt 2):R780-6. PubMed ID: 8853403
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of zeta-opioid receptor in human colon cancer.
Hytrek SD; Smith JP; McGarrity TJ; McLaughlin PJ; Lang CM; Zagon IS
Am J Physiol; 1996 Jul; 271(1 Pt 2):R115-21. PubMed ID: 8760211
[TBL] [Abstract][Full Text] [Related]
5. Opioid growth factor (OGF) inhibits anchorage-independent growth in human cancer cells.
Zagon IS; McLaughlin PJ
Int J Oncol; 2004 Jun; 24(6):1443-8. PubMed ID: 15138586
[TBL] [Abstract][Full Text] [Related]
6. Opioid growth factor receptor is unaltered with the progression of human pancreatic and colon cancers.
Zagon IS; McLaughlin PJ
Int J Oncol; 2006 Aug; 29(2):489-94. PubMed ID: 16820893
[TBL] [Abstract][Full Text] [Related]
7. Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor.
Zagon IS; Smith JP; McLaughlin PJ
Int J Oncol; 1999 Mar; 14(3):577-84. PubMed ID: 10024694
[TBL] [Abstract][Full Text] [Related]
8. Opioid growth factor tonically inhibits human colon cancer cell proliferation in tissue culture.
Zagon IS; Hytrek SD; McLaughlin PJ
Am J Physiol; 1996 Sep; 271(3 Pt 2):R511-8. PubMed ID: 8853370
[TBL] [Abstract][Full Text] [Related]
9. Opioid growth factor inhibition of a human squamous cell carcinoma of the head and neck in nude mice: dependency on the route of administration.
McLaughlin PJ; Stack BC; Braine KM; Ruda JD; Zagon IS
Int J Oncol; 2004 Jan; 24(1):227-32. PubMed ID: 14654962
[TBL] [Abstract][Full Text] [Related]
10. Opioid growth factor (OGF) inhibits the progression of human squamous cell carcinoma of the head and neck transplanted into nude mice.
McLaughlin PJ; Levin RJ; Zagon IS
Cancer Lett; 2003 Sep; 199(2):209-17. PubMed ID: 12969794
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma.
Zagon IS; Jaglowski JR; Verderame MF; Smith JP; Leure-Dupree AE; McLaughlin PJ
Cancer Chemother Pharmacol; 2005 Nov; 56(5):510-20. PubMed ID: 15947928
[TBL] [Abstract][Full Text] [Related]
12. Opioid growth factor and the treatment of human pancreatic cancer: a review.
Zagon IS; McLaughlin PJ
World J Gastroenterol; 2014 Mar; 20(9):2218-23. PubMed ID: 24605021
[TBL] [Abstract][Full Text] [Related]
13. Regulation of DNA synthesis of myocardial and epicardial cells in developing rat heart by [Met5]enkephalin.
McLaughlin PJ
Am J Physiol; 1996 Jul; 271(1 Pt 2):R122-9. PubMed ID: 8760212
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of the zeta-opioid receptor in developing rat heart.
McLaughlin PJ; Wu Y
Am J Physiol; 1997 Jun; 272(6 Pt 2):R1841-6. PubMed ID: 9227598
[TBL] [Abstract][Full Text] [Related]
15. Conserved expression of the opioid growth factor, [Met5]enkephalin, and the zeta (zeta) opioid receptor in vertebrate cornea.
Zagon IS; Sassani JW; Allison G; McLaughlin PJ
Brain Res; 1995 Feb; 671(1):105-11. PubMed ID: 7728521
[TBL] [Abstract][Full Text] [Related]
16. The opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor are present in human and mouse skin and tonically act to inhibit DNA synthesis in the epidermis.
Zagon IS; Wu Y; McLaughlin PJ
J Invest Dermatol; 1996 Mar; 106(3):490-7. PubMed ID: 8648182
[TBL] [Abstract][Full Text] [Related]
17. Expression of the opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor in head and neck squamous cell carcinoma.
Levin RJ; Wu Y; McLaughlin PJ; Zagon IS
Laryngoscope; 1997 Mar; 107(3):335-9. PubMed ID: 9121309
[TBL] [Abstract][Full Text] [Related]
18. Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neck.
Jaglowski JR; Zagon IS; Stack BC; Verderame MF; Leure-duPree AE; Manning JD; McLaughlin PJ
Cancer Chemother Pharmacol; 2005 Jul; 56(1):97-104. PubMed ID: 15791460
[TBL] [Abstract][Full Text] [Related]
19. Opioid growth factor regulates the cell cycle of human neoplasias.
Zagon IS; Roesener CD; Verderame MF; Ohlsson-Wilhelm BM; Levin RJ; McLaughlin PJ
Int J Oncol; 2000 Nov; 17(5):1053-61. PubMed ID: 11029512
[TBL] [Abstract][Full Text] [Related]
20. Elevated levels of opioid growth factor in the plasma of patients with pancreatic cancer.
Smith JP; Conter RL; Demers TM; McLaughlin PJ; Zagon IS
Pancreas; 2000 Aug; 21(2):158-64. PubMed ID: 10975710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]